Agarwal, S. K., Dash, S. C., Irshad, M., Raju, S., Singh, R., & Pandey, R. M. (2015). Prevalence of chronic renal failure in adults in Delhi, India. Nephrology Dialysis Transplantation, 20(8), 1638-1642.
Ahlawat, R., Tiwari, P., & D’Cruz, S. (2017). Direct Cost for Treating Chronic Kidney Disease at an Outpatient Setting of a Tertiary Hospital: Evidence from a Cross-Sectional Study. Value in health regional issues, 12, 36-40.
Bestvina, C. M., Zullig, L. L., & Zafar, Y. S. (2014). The implications of out-of-pocket cost of cancer treatment in the USA: a critical appraisal of the literature. Future Oncology, 10(14), 2189-2199.
Casilla-Lennon, M. M., Choi, S. K., Deal, A. M., Bensen, J. T., Narang, G., Filippou, P., ... & Smith, A. (2018). Financial toxicity among patients with bladder cancer: reasons for delay in care and effect on quality of life. The Journal of urology, 199(5), 1166-1173.
Delgado-Guay, M., Ferrer, J., Rieber, A. G., Rhondali, W., Tayjasanant, S., Ochoa, J., ... & Bruera, E. (2015). Financial distress and its associations with physical and emotional symptoms and quality of life among advanced cancer patients. The oncologist, 20(9), 10
92-1098.
De Souza, J. A., & Wong, Y. N. (2013). Financial distress in cancer patients. Journal of Medicine and the Person, 11(2), 73-77.
De Souza, J. A., Yap, B., Hlubocky, F. J., Ratain, M. J., Cella, D., & Daugherty, C. (2013). The development of a financial toxicity patient-reported outcome instrument (PRO) in cancer.
Durber, K., Halkett, G. K., McMullen, M., & Nowak, A. K. (2021). Measuring financial toxicity in Australian cancer patients–Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients. Asia?Pacific Journal of Clinical Oncology.
Edward, J. S., Rayens, M. K., Zheng, X., & Vanderpool, R. C. (2021). The association of health insurance literacy and numeracy with financial toxicity and hardships among colorectal cancer survivors. Supportive Care in Cancer, 1-8.
Ehlers, M., Bjurlin, M., Gore, J., Pruthi, R., Narang, G., Tan, R., ... & Smith, A. (2021). A national cross-sectional survey offinancial toxicity among bladder cancer patients. In Urologic Oncology: Seminars and Original Investigations (Vol. 39, No. 1, pp. 76-e
Esselen, K. M., Stack-Dunnbier, H., Gompers, A., & Hacker, M. R. (2021). Crowdsourcing to measure financial toxicity in gynecologic oncology. Gynecologic Oncology.
Gordon, L. G., Merollini, K., Lowe, A., & Chan, R. J. (2017). Financial toxicity-what it is and how to measure it. In Cancer Forum (Vol. 41, No. 2, p. 30). The Cancer Council Australia.
Gordon, L. G., Walker, S. M., Mervin, M. C., Lowe, A., Smith, D. P., Gardiner, R. A., & Chambers, S. K. (2017). Financial toxicity: apotential side effect of prostate cancer treatment among Australian men. European journal of cancer care, 26(1), e12392.
Laba, T. L., Essue, B. M., & Jan, S. (2015). Financing options to sustain Medicare: are we committed to universalism. Med J Aust, 203(6), 244-5.
Mejri, N., Berrazega, Y., Boujnah, R., Rachdi, H., El Benna, H., Labidi, S., & Boussen, H. (2021). Assessing the financial toxicity in Tunisian cancer patients using the Comprehensive Score for Financial Toxicity (COST). Supportive Care in Cancer, 1-7.
Nugent, R. A., Fathima, S. F., Feigl, A. B., & Chyung, D. (2011). The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clinical Practice, 118(3), c269-c277.
Politi, M. C., Yen, R. W., Elwyn, G., O'Malley, A. J., Saunders, C. H., Schubbe, D., ... & Durand, M. A. (2021). Women Who Are Young, Non?White, and with Lower Socioeconomic Status Report Higher Financial Toxicity up to 1 Year After Breast Cancer Surgery: A Mixed?Effects Regression Analysis. The oncologist, 26(1), e142-e152.
Smith, K. (2015). Financial toxicity impacts treatment adherence: oncologists must address costs with their patients. Am Health Drug Benefits, 8(3), 10-1.
Ting, C. Y., Teh, G. C., Yu, K. L., Alias, H., Tan, H. M., & Wong, L. P. (2020). Financial toxicity and its associations with health-related quality of life among urologic cancer patients in an upper middle-income country. Supportive Care in Cancer, 28(4), 1703-1715.
Ver Hoeve, E. S., Ali-Akbarian, L., Price, S. N., Lothfi, N. M., & Hamann, H. A. (2021). Patient-reported financial toxicity, quality of life, and health behaviors in insured US cancer survivors. Supportive Care in Cancer, 29(1), 349-358.
Williams, C. P., Gallagher, K. D., Deehr, K., Aswani, M. S., Azuero, A., Daniel, C. L., ... & Rocque, G. B. (2021). Quantifying treatment preferences and their association with financial toxicity in women with breast cancer. Cancer, 127(3), 449-457.
Workman, P., Draetta, G. F., Schellens, J. H., & Bernards, R. (2017). How much longer will we put up with $100,000 cancer drugs?. Cell, 168(4), 579-583.
Zafar, Y. S. (2015). Financial toxicity of cancer care: It’s time to intervene. Journal of the National Cancer Institute, 108(5)